Onconetix, Inc. (ONCO) Balance Sheet

NASDAQ: ONCOAssets, liabilities, debt and equity over 7 years.

ONCO balance sheet, 2025

December 31, 2025 · U.S. dollars

$24.9M assets = $9.2M liabilities + $15.8M equity

What it owns$24.9MCash & ST investments: $5.2M (20.9%)Cash & ST investments$5.2M · 21%Receivables: $296,866 (1.2%)Inventory: $149,961 (0.6%)Other current: $399,293 (1.6%)PP&E: $85,859 (0.3%)Goodwill & intangibles: $18.5M (74.4%)Goodwill & intangibles$18.5M · 74%Other non-current: $225,000 (0.9%)=How it is financed$24.9MCurrent liabilities: $9.1M (36.7%)Current liabilities$9.1M · 37%Other LT liabilities: $24,362 (0.1%)Shareholders’ equity: $15.8M (63.3%)Shareholders’ equity$15.8M · 63%

Both columns are drawn to the same scale: what ONCO owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ONCO financial health

Current ratio0.66
Tight · current assets cover current liabilities 0.66×
Debt / equity0.00
Low leverage · $0.00 of debt for each $1 of equity
Equity / assets63.2%
Equity-funded · of assets funded by shareholders
Cash / debt10,703.8%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles74.4%
Mostly intangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

ONCO balance sheet trends, 2019–2025

Onconetix, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$6.1M2019$24.9M2025+26.5%/yr
Total liabilities$82,6212019$9.2M2025+119.2%/yr
Shareholders’ equity$6.0M2019$15.8M2025+17.5%/yr
Cash & short-term investments$6.1M2019$5.2M2025−2.4%/yr
Total debt$9.9M2023$48,7742025−93.0%/yr
Net cash (debt)−$5.3M2023$5.2M2025+$10.5M
Working capital$6.0M2019−$3.1M2025−$9.1M
Current ratio79.9820190.662025−79.31
Debt / equity0.9820240.002025−0.98

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ONCO assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ONCO liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ONCO debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ONCO balance sheet

Onconetix, Inc. annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$5.2M$646,500$4.6M$25.8M$1.9M$4.3M$6.1M
Cash & equivalents$5.2M$646,500$4.6M$25.8M$1.9M$4.3M$6.1M
Receivables$296,866$96,308$149,731$35,850$152,524$44,805$8,330
Inventory$149,961$64,079$364,052$0$757,646−$35,000$0
Other current assets$399,293$143,380$770,153$469,232$234,551$277,853$8
Total current assets$6.1M$950,267$5.8M$26.3M$3.1M$4.6M$6.1M
Property, plant & equipment (net)$85,859$182,323$209,196$14,089$11,502$15,667$6,931
Goodwill & intangible assets$18.5M$27.0M$81.1M$0$0$0$0
Long-term investments$0$0$0$0$0$0$0
Other non-current assets$225,000$0$383,536$38,617$0$199,934$15,000
Total assets$24.9M$28.2M$87.5M$26.3M$3.1M$4.8M$6.1M
Liabilities
Accounts payable$1.8M$3.8M$5.3M$1.5M$582,605$68,668$18,377
Short-term debt$24,412$9.4M$9.7M————
Total current liabilities$9.1M$18.3M$17.2M$3.9M$1.6M$68,668$75,762
Long-term debt$0$0$118,857$0$0$0$0
Lease obligations$48,774$119,427$148,542$0———
Other long-term liabilities$24,362$280,879$68.8M$0$0$9,642$6,859
Total liabilities$9.2M$18.6M$86.1M$3.9M$1.6M$78,310$82,621
Shareholders' equity
Common stock & paid-in capital$15$118$6$157$32$32$8
Retained earnings (deficit)−$131.2M−$115.7M−$56.8M−$19.4M−$6.0M−$2.5M−$939,870
Accumulated other comprehensive income−$231,028−$2.7M$2.4M———−$8
Minority interest—$0$7.0M$0———
Total shareholders' equity$15.8M$9.6M−$5.6M$22.4M$1.4M$4.7M$6.0M
Key figures
Total debt$48,774$9.4M$9.9M————
Net cash (debt)$5.2M−$8.8M−$5.3M————
Working capital−$3.1M−$17.3M−$11.4M$22.3M$1.4M$4.5M$6.0M
Tangible book value−$2.8M−$17.4M−$86.7M$22.4M$1.4M$4.7M$6.0M
Book value per share$4.80——————
Shares outstanding3.3M——————
Current ratio0.660.050.346.691.8866.9479.98
Quick ratio0.600.040.276.571.2763.4079.98
Debt / equity0.000.98—————
Equity / assets63.2%34.1%−6.4%85.1%46.9%98.4%98.6%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 13, 2026); data from EODHD.

ONCO financial position

At the end of fiscal 2025 (December 31, 2025), Onconetix had total assets of $24.9 million (down 11.5% from a year earlier), total liabilities of $9.2 million and shareholders' equity of $15.8 million. It held $5.2 million in cash and short-term investments against $0.0 million of debt, a net cash position of $5.2 million. Its current ratio was 0.66. In the latest quarter (ended June 30, 2026) total assets were $16.4 million and equity $13.5 million.

Related: ONCO income statement, ONCO cash flow statement, ONCO key metrics. See the ONCO stock overview for the latest quote and news.

ONCO balance sheet FAQ

What are Onconetix's total assets?

Onconetix reported total assets of $24.9 million at the end of fiscal 2025 (December 31, 2025), compared with $28.2 million a year earlier.

How much debt does Onconetix have?

Onconetix had $0.0 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.00.

How much cash does Onconetix have?

Onconetix held $5.2 million in cash and short-term investments at the end of fiscal 2025; with $0.0 million of debt that is net cash of $5.2 million.

What is Onconetix's book value?

Onconetix's shareholders' equity (book value) was $15.8 million at the end of fiscal 2025, or $4.80 per share.

What is Onconetix's current ratio?

Onconetix had current assets of $6.1 million and current liabilities of $9.1 million, a current ratio of 0.66 (current liabilities exceed current assets).

How much goodwill does Onconetix have?

Onconetix carried $18.5 million of goodwill and intangible assets, 74.4% of total assets, at the end of fiscal 2025.

Biotechnology: balance sheet